The Latest Breaking News from Nasdaq

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.

Good Morning Everyone! Remember, it’s the best time to buy great companies at a great price and leave them alone.

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday.

Here's a roundup of top developments in the biotech space over the last 24 hours:

InMed Pharmaceuticals Inc. (NASDAQ: INM) provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment

CNBC

The unfolding week is likely to test the nerves of investors, as they get to digest major market-moving catalysts, both on the economic and corporate fronts. A Fed meeting, second-quarter U.S. GDP data, and big tech earnings, all make things interesting. Ahead of the news-heavy week, here's a recap of…

Shark Week 2022 is arriving, and it's bringing non-fungible tokens along with it. Here’s a look at the details and how viewers can get free NFTs for watching content.